Association of longevity with IL‐10 −1082 G/A and TNF‐α−308 G/A polymorphisms

Cytokines are crucial for the regulation of inflammation development in humans. Many studies have shown that variations in cytokine genes might play a role in determining human longevity. This study examined the changes in the gene pool relevant to the −308 G/A polymorphism in the promoter region of the proinflammatory cytokine tumour necrosis factor (TNF)‐α gene and the −1082 G/A polymorphism in the promoter region of anti‐inflammatory cytokine interleukin (IL)‐10 gene with aging and survival selection occurs in the Jordanian population. IL‐10 −1028 G/A and TNF‐α−308 G/A were genotyped in 119 randomly selected elderly subjects (41 women and 78 men) with a mean age of 90.2 years and young control subjects of 118 (46 women and 72 men) with a mean age of 31.9 years. No significant differences were found in the genotype and allele frequencies of TNF‐α gene variants between the two groups (P > 0.05) while the IL‐10 genotype and allele frequencies were significantly associated with longevity in men (P < 0.05) but not in women (P < 0.05). Thus, IL‐10 −1028 G/A polymorphism seems to play a role in the pathway to longevity in Jordanian men.

[1]  K. Koh,et al.  Counter-stress effects of relaxation on proinflammatory and anti-inflammatory cytokines , 2008, Brain, Behavior, and Immunity.

[2]  Tamara Cacev,et al.  Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. , 2008, Carcinogenesis.

[3]  R. Lipton,et al.  Adiponectin levels and genotype: a potential regulator of life span in humans. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  C. Franceschi,et al.  A genetic-demographic approach reveals male-specific association between survival and tumor necrosis factor (A/G)-308 polymorphism. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[5]  C. Franceschi,et al.  The immune system in extreme longevity , 2008, Experimental Gerontology.

[6]  N. Schork,et al.  Successful Aging: From Phenotype to Genotype , 2007, Biological Psychiatry.

[7]  R. May Gender, immunity and the regulation of longevity. , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.

[8]  J. Satoh,et al.  Association of TNF-α Gene Promoter C-857T Polymorphism with Higher Serum LDL Cholesterol Levels and Carotid Plaque Formation in Japanese Patients with Type 2 Diabetes , 2007 .

[9]  C. Falcone,et al.  Inflammation and Atherosclerosis: The Role of TNF and TNF Receptors Polymorphisms in Coronary Artery Disease , 2007, International journal of immunopathology and pharmacology.

[10]  A. Cayuela,et al.  Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis , 2006, Critical care.

[11]  C. Caruso,et al.  Inflammation, Longevity, and Cardiovascular Diseases , 2006, Annals of the New York Academy of Sciences.

[12]  W. Griffin,et al.  Inflammation and neurodegenerative diseases. , 2006, The American journal of clinical nutrition.

[13]  J. Edelberg,et al.  PDGF-AB-based functional cardioprotection of the aging rat heart , 2006, Experimental Gerontology.

[14]  C. Franceschi,et al.  Genes, ageing and longevity in humans: Problems, advantages and perspectives , 2006, Free radical research.

[15]  C. Franceschi,et al.  Study of the Association with −330T/G IL-2 in a Population of Centenarians from Centre and South Italy , 2005, Biogerontology.

[16]  Joon-Yong Park,et al.  Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. , 2005, Cancer letters.

[17]  T. Kirkwood Time of our lives , 2005 .

[18]  Serkalem Demissie,et al.  Disentangling the genetic determinants of human aging: biological age as an alternative to the use of survival measures. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[19]  C. Franceschi,et al.  Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians , 2005, Mechanisms of Ageing and Development.

[20]  C. Franceschi,et al.  Aging, Longevity, Inflammation, and Cancer , 2004, Annals of the New York Academy of Sciences.

[21]  Claudio Franceschi,et al.  The G/C915 polymorphism of transforming growth factor β1 is associated with human longevity: a study in Italian centenarians , 2004, Aging cell.

[22]  C. Franceschi,et al.  Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR)γ-2 with longevity , 2004, Experimental Gerontology.

[23]  L. Ferrucci,et al.  Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians , 2004, Aging clinical and experimental research.

[24]  H. Bruunsgaard,et al.  Inflammatory mediators in the elderly , 2004, Experimental Gerontology.

[25]  Snejina Michailova,et al.  Immunological markers contributing to successful aging in Bulgarians , 2004, Experimental Gerontology.

[26]  C. Franceschi,et al.  The −174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing , 2004, Experimental Gerontology.

[27]  C. Franceschi,et al.  Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 −1082 promoter SNP and its interaction with TNF-α −308 promoter SNP , 2003, Journal of medical genetics.

[28]  C. Caruso,et al.  IL-10 and TNF-α polymorphisms in a sample of sicilian patients affected by tuberculosis: implication for ageing and life span expectancy , 2003, Mechanisms of Ageing and Development.

[29]  Claudio Franceschi,et al.  The role of IL-1 gene cluster in longevity: a study in Italian population , 2003, Mechanisms of Ageing and Development.

[30]  C. Franceschi,et al.  Association between the MHC class I gene HFE polymorphisms and longevity: a study in Sicilian population , 2002, Genes and Immunity.

[31]  L Scola,et al.  Gender-specific association between −1082 IL-10 promoter polymorphism and longevity , 2002, Genes and Immunity.

[32]  Claudio Franceschi,et al.  Allele frequencies of +874T→A single nucleotide polymorphism at the first intron of interferon-γ gene in a group of Italian centenarians , 2002, Experimental Gerontology.

[33]  M. Jylhä,et al.  Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-α genes in Finnish nonagenarians , 2001, Mechanisms of Ageing and Development.

[34]  B. Weir,et al.  Sex-specific longevity associations defined by Tyrosine Hydroxylase–Insulin–Insulin Growth Factor 2 haplotypes on the 11p15.5 chromosomal region , 2001, Experimental Gerontology.

[35]  C. Franceschi,et al.  A gender–dependent genetic predisposition to produce high levels of IL‐6 is detrimental for longevity , 2001, European journal of immunology.

[36]  A. Bateman,et al.  IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma , 2001, Genes and Immunity.

[37]  C. Dinarello,et al.  Proinflammatory cytokines. , 2000, Chest.

[38]  A. Hajeer,et al.  TNF‐α gene polymorphism: Clinical and biological implications , 2000 .

[39]  J. Bidwell,et al.  CYTOKINE GENE POLYMORPHISM , 2000 .

[40]  F. Pociot,et al.  Cytokine gene polymorphism in human disease: on-line databases , 1999, Genes and Immunity.

[41]  P. Woo,et al.  Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[42]  N. Makhatadze Tumor necrosis factor locus: genetic organisation and biological implications. , 1998, Human immunology.

[43]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  L. Abraham,et al.  The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .

[45]  C. Brayne,et al.  Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. , 1997, Atherosclerosis.

[46]  M. Lazarus,et al.  An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[47]  George Murray,et al.  Longevity , 1886, The Hospital.

[48]  J. Satoh,et al.  Association of TNF-alpha gene promoter C-857T polymorphism with higher serum LDL cholesterol levels and carotid plaque formation in Japanese patients with type 2 diabetes. , 2007, The Tohoku journal of experimental medicine.

[49]  T. Kirkwood Time of our lives. What controls the length of life? , 2005, EMBO reports.

[50]  M. Rose-Zerilli,et al.  Interleukin-10 Polymorphisms, Cancer Susceptibility and Prognosis , 2005, Familial Cancer.

[51]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[52]  A. Hajeer,et al.  TNF-alpha gene polymorphism: clinical and biological implications. , 2000, Microscopy research and technique.

[53]  S. Khoury,et al.  Mortality and causes of death in Jordan 1995-96: assessment by verbal autopsy. , 1999, Bulletin of the World Health Organization.

[54]  L. Abraham,et al.  The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. , 1997, Molecular immunology.